ManpowerGroup heads into its Q2 earnings tomorrow with short sellers notably more aggressive than they were a month ago — while the broader staffing sector rallied around it on Tuesday.
The short interest story is the sharpest signal heading into the print. Bears have added meaningfully in recent weeks: short interest climbed 22% over the past month to 14.3% of the free float, with the most pronounced jump arriving in the last week alone — up nearly 11%. That is a high and rising level for a company of this size. Despite the growing short position, borrowing conditions remain relaxed. Availability is extremely loose at 1,331% — more than thirteen shares available to borrow for every one already shorted — and the cost to borrow is low at 0.58%, even after rising 30% on the week. There is no squeeze pressure here; the borrow market is accommodating fresh shorts with ease. Options positioning is not adding much additional signal: the put/call ratio of 0.52 is barely above its 20-day average, with a z-score near zero, suggesting options traders are not materially more defensive than usual.
The divergence with sector peers on Tuesday is worth noting. MAN fell 3.5% while closest peer surged nearly 10% — likely on a strong Robert Half earnings reaction — and , , , and all posted gains of 3-10%. ManpowerGroup's underperformance on a day when the sector broadly rallied sharpens the stakes around tomorrow's release.
The bull and bear cases are clearly drawn. Bulls point to momentum in the Experis segment, cost discipline, and forward EPS estimates that have ticked higher — the 12-month forward EPS growth factor ranks in the 89th percentile. The stock also trades at an extreme value discount: price-to-book below 0.71 and an EV/EBITDA under 6x make it one of the cheapest names in its peer group. Bears see a company guiding for 1–5% revenue declines year-on-year, gross margins compressed to 17.1%, and Northern European revenues — roughly a fifth of the total — down 16% year-on-year. The EPS surprise factor ranking of just 15 out of 100 suggests the company has a weak track record of beating estimates. On the analyst front, UBS raised its target this morning to $41 from $33 while keeping a Neutral rating — a meaningful upward revision that still stops short of enthusiasm, with the mean Street target at $37.61 against a current price of $39.18.
History adds caution. The May 2026 print sent the stock down nearly 5% on the day and 15% over the following five sessions. The April 2026 result was more mixed — a modest 1.3% gain on the day that still eroded to a 4.8% loss by the end of the week. Tomorrow's print will test whether the sharp short interest build of the past month reflects genuine fundamental deterioration — or leaves a crowded short trade vulnerable if results come in ahead of depressed expectations.
See the live data behind this article on ORTEX.
Open MAN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
